Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check5 days agoChange DetectedFooter now displays Revision: v3.4.3, replacing Revision: v3.4.2 as part of a site update. This change does not affect study data or content on the page.SummaryDifference0.0%

- Check12 days agoChange DetectedRecruitment status updated from Recruiting to Active, not recruiting; the update adds Study Status and Contacts/Locations sections on 2026-02-27.SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new Revision: v3.4.2 was added to the History, while the funding-status notice and Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about government funding status was added and the revision updated to v3.4.1 on 2026-02-02, while the prior v3.4.0 revision was deleted on 2026-01-05.SummaryDifference0.6%

- Check48 days agoChange DetectedThe update introduces UI elements (Show glossary), color-highlights for changes, and revision metadata on the history page, which are cosmetic and do not modify study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; no study data or page content changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.